RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Development and validation of a high- throughput method for the determination of titanium dioxide in rodent lung and lung-associated lymph node tissues
Levine, K., Fernando, R., Lang, M., Essader, A., & Wong, B. A. (2003). Development and validation of a high- throughput method for the determination of titanium dioxide in rodent lung and lung-associated lymph node tissues. Analytical Letters, 36(3), 563-576. https://doi.org/10.1081/AL-120018244
There is a need to determine the tissue burdens of inhaled titanium dioxide due to the widespread industrial use of this compound. A high-throughput method for the determination of TiO2 as titanium in rodent lung and lung-associated lymph node tissues by inductively coupled plasma optical emission spectrometry (ICP-OES) was developed and validated. Samples were digested in open-vessel, disposable centrifuge tubes in the presence of nitric and hydrofluoric acids. The determined method quantitation limit (MQL) was 4.2 µg TiO2/g tissue. Replicate control samples prepared at this level were determined with a high level of accuracy (100%) and precision (2% RSD). After validation, the described method was applied to determine the concentration of TiO2 (as titanium) in 600 rodent tissue samples spanning a 16-month time period. During this time period, laboratory control samples (n = 48) were analyzed to assess the long-term precision and accuracy of the method. The average recovery of titanium in these samples was 102±4.8%.
